Literature DB >> 16123809

TGF-beta and epithelial-to-mesenchymal transitions.

Jiri Zavadil1, Erwin P Böttinger.   

Abstract

Remarkable phenotype plasticity of epithelial cells underlies morphogenesis, epithelial repair and tumor invasiveness. Detailed understanding of the contextual cues and molecular mediators that control epithelial plasticity will be required in order to develop viable therapeutic approaches targeting epithelial-to-mesenchymal transition (EMT), an advanced manifestation of epithelial plasticity. Members of the transforming growth factor (TGF-beta) family of growth factors can initiate and maintain EMT in a variety of biological systems and pathophysiological context by activating major signaling pathways and transcriptional regulators integrated in extensive signaling networks. Here we will review the distinct physiological contexts of EMT and the underlying molecular signaling networks controlled by TGF-beta.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16123809     DOI: 10.1038/sj.onc.1208927

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  688 in total

1.  TGF-β-induced activation of mTOR complex 2 drives epithelial-mesenchymal transition and cell invasion.

Authors:  Samy Lamouille; Erin Connolly; James W Smyth; Rosemary J Akhurst; Rik Derynck
Journal:  J Cell Sci       Date:  2012-03-07       Impact factor: 5.285

2.  Eosinophilic esophagitis: epithelial mesenchymal transition contributes to esophageal remodeling and reverses with treatment.

Authors:  Amir F Kagalwalla; Noorain Akhtar; Samantha A Woodruff; Bryan A Rea; Joanne C Masterson; Vincent Mukkada; Kalyan R Parashette; Jian Du; Sophie Fillon; Cheryl A Protheroe; James J Lee; Katie Amsden; Hector Melin-Aldana; Kelley E Capocelli; Glenn T Furuta; Steven J Ackerman
Journal:  J Allergy Clin Immunol       Date:  2012-04-01       Impact factor: 10.793

3.  Extracellular matrix bioengineering and systems biology approaches in liver disease.

Authors:  Natalia Nieto; Matthias P Lutolf
Journal:  Syst Synth Biol       Date:  2011-06-17

4.  miR-21 and miR-31 converge on TIAM1 to regulate migration and invasion of colon carcinoma cells.

Authors:  Charisa L Cottonham; Satoshi Kaneko; Lan Xu
Journal:  J Biol Chem       Date:  2010-09-07       Impact factor: 5.157

5.  The regenerative potential of the kidney: what can we learn from developmental biology?

Authors:  Franca Anglani; Federica Mezzabotta; Monica Ceol; Rosalba Cristofaro; Dorella Del Prete; Angela D'Angelo
Journal:  Stem Cell Rev Rep       Date:  2010-12       Impact factor: 5.739

6.  The transcription factor snail mediates epithelial to mesenchymal transitions by repression of estrogen receptor-alpha.

Authors:  Archana Dhasarathy; Masahiro Kajita; Paul A Wade
Journal:  Mol Endocrinol       Date:  2007-08-30

7.  Integrin alpha3beta1 potentiates TGFbeta-mediated induction of MMP-9 in immortalized keratinocytes.

Authors:  John M Lamar; Vandana Iyer; C Michael DiPersio
Journal:  J Invest Dermatol       Date:  2007-08-30       Impact factor: 8.551

8.  Epithelial-mesenchymal transition induced by growth suppressor p12CDK2-AP1 promotes tumor cell local invasion but suppresses distant colony growth.

Authors:  Takanori Tsuji; Soichiro Ibaragi; Kaori Shima; Miaofen G Hu; Miki Katsurano; Akira Sasaki; Guo-fu Hu
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

9.  Low-level laser therapy promotes proliferation and invasion of oral squamous cell carcinoma cells.

Authors:  Águida Cristina Gomes Henriques; Fernanda Ginani; Ruth Medeiros Oliveira; Tatjana Souza Lima Keesen; Carlos Augusto Galvão Barboza; Hugo Alexandre Oliveira Rocha; Jurema Freire Lisboa de Castro; Ricardo Della Coletta; Roseana de Almeida Freitas
Journal:  Lasers Med Sci       Date:  2014-02-14       Impact factor: 3.161

10.  TGF-β regulation of gene expression at early and late stages of HPV16-mediated transformation of human keratinocytes.

Authors:  Sangeeta Kowli; Rupa Velidandla; Kim E Creek; Lucia Pirisi
Journal:  Virology       Date:  2013-09-19       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.